Overview

A Study of Propranolol to Treat Kaposi Sarcoma

Status:
Not yet recruiting

Trial end date:
2028-08-01

Target enrollment:

Participant gender:

Summary

A clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.

Phase:

Phase 2

Details

Lead Sponsor:

AIDS Malignancy Consortium

Collaborator:

National Cancer Institute (NCI)

Treatments:

Propranolol